Downloadable Slides

Share

Program Content

Activities

  • Treatment of HER2-Low Breast Cancer
    Establishing HER2-Targeted Therapies in the Treatment of HER2-Low Breast Cancer
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 02, 2023

  • TROP-2 in breast cancer
    Incorporating TROP-2–Targeted Therapies Into the Breast Cancer Landscape
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 02, 2023

  • ADC-Associated AEs
    Practical Adverse Event Management for Optimal Therapeutic Outcomes
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 02, 2023

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., and Gilead Sciences, Inc.

AstraZeneca

Daiichi Sankyo

Gilead Sciences, Inc.